Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo - Wikidata - awgldk - TriplyDB

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo

http://www.wikidata.org/entity/Q37057434

about

Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporter Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68 Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Characterization of metastasis formation and virotherapy in the human C33A cervical cancer model.Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.Combination treatment with oncolytic Vaccinia virus and cyclophosphamide results in synergistic antitumor effects in human lung adenocarcinoma bearing mice Significant Growth Inhibition of Canine Mammary Carcinoma Xenografts following Treatment with Oncolytic Vaccinia Virus GLV-1h68.Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68 Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.Oncolytic vaccinia virus therapy of salivary gland carcinoma Effective oncolytic vaccinia therapy for human sarcomas.The vaccinia virus A56 protein: a multifunctional transmembrane glycoprotein that anchors two secreted viral proteins Vaccinia virus GLV-1h153 is a novel agent for detection and effective local control of positive surgical margins for breast cancer Silk-elastin-like protein polymer matrix for intraoperative delivery of an oncolytic vaccinia virus Oncolytic vaccinia therapy of squamous cell carcinoma.Vaccinia virus GLV-1h153 in combination with 131I shows increased efficiency in treating triple-negative breast cancer.Anaplastic thyroid cancer: a comprehensive review of novel therapy.Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.Genetically Engineered Vaccinia Viruses As Agents for Cancer Treatment, Imaging, and Transgene Delivery.Epithelial-mesenchymal transition enhances response to oncolytic herpesviral therapy through nectin-1.Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients.

P2860

Q21134124-060BF830-0CAC-4E19-8D07-54E982277F7F Q21245462-CFF44015-88AF-4DF3-B81D-7A8095EB21A5 Q24655930-6394AEC8-6D97-457A-9951-B5599DD17782 Q28729948-9EDB42C1-372D-4384-965B-6B6E5BFDA408 Q28742749-E58C2EA4-838F-485B-AC92-43731E1B1757 Q33479314-EC3924DC-B0BF-4A0F-B13B-3A7123C7190B Q33691759-BC5EE533-3BEF-43EC-AC21-C907CE6CDB08 Q33700061-300E97EC-ABEF-4174-86B0-6CC1463AA33A Q33772011-71FF0AF1-64D3-4E51-95BD-66C6BA4AD2E1 Q33927165-43D002C9-701E-4CFF-B101-2402D8167EED Q33988096-74E6E262-EDE1-433D-8FA0-53339E3FC4F3 Q34051784-97976A44-F560-43E6-A8ED-A3728BFE77AB Q35338417-3377254B-8F6B-4679-B27F-781D6B3527D8 Q35549696-CC1FC3C0-DEE0-4375-8956-F2790E522FF7 Q35954052-CF5C50E7-8EBC-4BD7-B9D7-89AECFDA4B5D Q35963805-FEDDD6BE-303C-46CC-9094-46EBC37D8BF7 Q36903415-4AC1F038-F394-495B-ADE6-038C55F8C2BD Q37156574-EA2E5172-7CAC-42A0-AC37-33DF9E87C6A1 Q37270539-495A150B-FEB7-4B47-A8AE-EC9E5B34D444 Q37734548-030D7D3A-C251-4E4D-BBD1-62B159C5E4F6 Q37854708-71FF5B23-C5E0-48FD-BC83-55BBA3FED2D5 Q38264652-6B8320C6-D44A-4376-A8F2-A99449E06D3A Q38673968-F9F5E465-DBE6-4B74-833A-0B0F2865BDDE Q39020984-D897F70A-E0A4-44E3-A49F-DABC71DD8B03 Q39159172-F5B89885-3EFC-4333-95D7-C02B06D9318C Q39175316-DDDB8B43-F8DE-4071-AEA6-57AF705C8A54 Q39315516-1F624490-4A1E-429C-934D-9366BC3C4D2C Q51043512-915A16E4-BB68-4773-88CB-ABF799D2D630

P2860

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo

http://www.wikidata.org/entity/Q37057434

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo

@en

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.

@nl

type

label

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo

@en

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.

@nl

prefLabel

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo

@en

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.

@nl

P1433

Q37057434-C5108229-5DFA-4D90-90AA-4E1ACEC1F588

P1476

Q37057434-4453D826-39AB-4667-9619-C868CB29FD43

P2093

Q37057434-2475F829-3E2F-4565-82A7-221425E59314

Q37057434-3356349D-949F-43B1-8716-3B734B3E5CD9

Q37057434-40891E12-A5AA-4C56-B2E7-574FFC9C6912

Q37057434-6FAE0100-E9B8-4E76-9157-64B86054A52D

Q37057434-75387571-09CC-4A2D-AB86-218655414C01

Q37057434-89498475-76C3-4A41-9D37-E8D6ABE7E874

Q37057434-9F376744-0415-486E-A79B-79470CAC627E

Q37057434-9FDB956C-A4B2-4F28-A7B3-AC728444D4B9

P2860

Q37057434-31CFD3BE-89DD-4D2E-9EC9-751ED1640FD7

Q37057434-4189E099-868D-47CF-BDFB-77749FCE45A5

Q37057434-620E3AAA-ECF2-45E7-AF19-0CEABA09AC08

Q37057434-903B303D-4E62-4B93-BD58-9EBBD2C6A93A

Q37057434-93F3A3A7-73E8-4AC7-B2B1-D16C68015BE5

Q37057434-9496FEC8-DA29-46B5-BF4F-C90DAB7AF811

Q37057434-9711BE66-503A-468B-B80D-F47A4388CDB8

Q37057434-9B3B5CFD-549F-4B1C-9318-DD1167B96396

Q37057434-A73BAF3D-7A64-4E08-85BB-181441935C49

Q37057434-BB043A1C-796F-4CA9-9C43-D875A2D1094F

P304

Q37057434-52951BD4-7DA9-4311-8D5C-6149CA48B780

P31

Q37057434-48745889-1B29-403B-8418-864CE1C36161

P356

Q37057434-A2E0B45C-AD06-44CD-8280-6DFC7B551C37

P407

Q37057434-03CC87B8-1EDB-4654-BB25-C5F986FE833C

P433

Q37057434-3C84F144-E910-47CD-B605-6130F58F083C

P478

Q37057434-28DA93F1-234F-4197-86D6-18AF4B8C7760

P50

Q37057434-4AF7077A-54DC-4BEB-B931-1659DA6F9271

Q37057434-896E09FD-3F1F-4068-8DEA-ADA8E567E9C0

Q37057434-967808B4-C4E7-430F-AC82-430BED69F1CD

Q37057434-A491D561-403A-4756-99DF-8558C5C67CE0

P577

Q37057434-AB70F57A-4A77-4D91-8AE2-E9C4900B4A2F

P5875

Q37057434-BA33982E-43A5-4640-ACD3-2AF297C760AF

P698

Q37057434-BD212ECE-4DA0-4F10-B008-B0016F5EF99C

P921

Q37057434-AE41CD46-0AE1-4A95-93AE-ABA0A0A4DF89

P932

Q37057434-E8ECB55E-2B8B-4590-84CF-A8B6D6B3FD8C

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo

@en

P2093

Chun-Hao Chen

http://www.w3.org/2001/XMLSchema#string

Lorena Gonzalez

http://www.w3.org/2001/XMLSchema#string

Nanhai Chen

http://www.w3.org/2001/XMLSchema#string

Peter Brader

http://www.w3.org/2001/XMLSchema#string

Qian Zhang

http://www.w3.org/2001/XMLSchema#string

Richard J Wong

http://www.w3.org/2001/XMLSchema#string

Sen Li

http://www.w3.org/2001/XMLSchema#string

Yong A Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group.

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins.

Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus.

Fighting cancer with vaccinia virus: teaching new tricks to an old dog.

Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery.

Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus.

Treatment of aggressive thyroid cancer with an oncolytic herpes virus.

Experience of anti-vaccinia immunoglobulin in the United Kingdom.

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.

P304

4403-4407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2008-0316

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P50

Aladar A Szalay

P577

2008-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23165696

http://www.w3.org/2001/XMLSchema#string

P698

18697871

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3728375

http://www.w3.org/2001/XMLSchema#string